Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease

BACKGROUND: Currently, it is unclear whether the progression of chronic kidney disease (CKD) could be an independent predictor of antibody response after administration of a COVID-19 vaccine. This study aimed to investigate the immune response to COVID-19 vaccination in patients with CKD stage G4 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsunami, Masatoshi, Suzuki, Tomo, Fukuda, Junko, Terao, Toshiki, Ukai, Kohei, Sugihara, Shinnosuke, Toishi, Takumi, Nagaoka, Kanako, Nakata, Mayumi, Ohara, Mamiko, Yashima, Jun, Kuji, Hiroshi, Matsue, Kosei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980785/
https://www.ncbi.nlm.nih.gov/pubmed/35402003
http://dx.doi.org/10.1186/s41100-022-00402-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980785/
https://www.ncbi.nlm.nih.gov/pubmed/35402003
http://dx.doi.org/10.1186/s41100-022-00402-x

Ejemplares similares